A Martin Shkreli wannabe defends a big spike in drug price and earns a Twitter lashing from the FDA's commish
There’s a broad consensus that the pharma industry has at least temporarily checked its impulse to keep hiking prices on their portfolios. But a small …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
